Recent cases of polio in PNG have concerned health authorities. Here’s what to know.
- Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
A variante JN.1 tornou-se dominante na Austrália e em todo o mundo, causando grandes ondas de infecções. Veja o que sabemos sobre ela até o momento e por que ela é tão importante.
The JN.1 variant has become dominant in Australia and around the world, causing large waves of infections. Here’s what we know about it so far – and why it’s so important.
A promising collection of studies suggests taking antivirals such as Paxlovid during an infection could reduce the risk of developing long COVID.
Australia seems to be focusing on boosters for people aged 75 and over, with its latest recommendations. But that may change.
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.
Rolling out vaccines, sticking with public health measures, and keeping misinformation and complacency in check. These are just some of what to expect as the pandemic enters its second year.
A new, combination hepatitis C therapy could shorten treatment times, reduce side effects and improve health outcomes for people who also have HIV, early trial results show. Worldwide, around one-third…
Tuberculosis, or consumption as it used to be known, sounds like a disease that we’ve managed to fight off for good. But a drug-resistant strain of the bacteria that causes it is making a comeback, and…
- Location: Melbourne, Australia
- Website
- X (formerly Twitter): @majumdar_suman
- Article Feed
- ORCID
-
- Joined
